UY29244A1 - MEDICAL COMBINATIONS - Google Patents

MEDICAL COMBINATIONS

Info

Publication number
UY29244A1
UY29244A1 UY29244A UY29244A UY29244A1 UY 29244 A1 UY29244 A1 UY 29244A1 UY 29244 A UY29244 A UY 29244A UY 29244 A UY29244 A UY 29244A UY 29244 A1 UY29244 A1 UY 29244A1
Authority
UY
Uruguay
Prior art keywords
combinations
medical combinations
medical
azoniabicyclo
octanes
Prior art date
Application number
UY29244A
Other languages
Spanish (es)
Inventor
Michael R Palovich
Dramane Ibrahim Laine
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of UY29244A1 publication Critical patent/UY29244A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a los derivados olefínicos de 8-azoniabiciclo (3.2.1) octanos, a composiciones farmacéuticas de los mismos y a su uso en el tratamiento de enfermedades mediadas por el receptor muscarínico de acetilcolina del tracto respiratorio, combinaciones de los mismos y métodos para utilizarlos.The invention relates to the olefinic derivatives of 8-azoniabicyclo (3.2.1) octanes, pharmaceutical compositions thereof and their use in the treatment of diseases mediated by the muscarinic acetylcholine receptor of the respiratory tract, combinations thereof and methods. to use them

UY29244A 2004-12-06 2005-12-02 MEDICAL COMBINATIONS UY29244A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63366904P 2004-12-06 2004-12-06

Publications (1)

Publication Number Publication Date
UY29244A1 true UY29244A1 (en) 2006-05-31

Family

ID=36578446

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29244A UY29244A1 (en) 2004-12-06 2005-12-02 MEDICAL COMBINATIONS

Country Status (5)

Country Link
AR (1) AR054411A1 (en)
PE (1) PE20061162A1 (en)
TW (1) TW200633706A (en)
UY (1) UY29244A1 (en)
WO (1) WO2006062883A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050250A1 (en) 2003-07-17 2005-04-08 Glaxo Group Ltd ANTAGONISTS OF ACETYLCHOLIN MUSCARINAL RECEPTORS
CN1893948A (en) 2003-10-14 2007-01-10 葛兰素集团有限公司 Muscarinic acetylcholine receptor antagonists
BRPI0415281A (en) 2003-10-17 2006-12-19 Glaxo Group Ltd muscarinic acetylcholine receptor antagonists
PE20050489A1 (en) 2003-11-04 2005-09-02 Glaxo Group Ltd ANTAGONISTS OF MUSCARINE ACETYLCHOLINE RECEPTORS
US7384946B2 (en) 2004-03-17 2008-06-10 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
PE20060259A1 (en) 2004-04-27 2006-03-25 Glaxo Group Ltd QUINUCLIDINE COMPOUNDS AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR
EP1747219A4 (en) 2004-05-13 2010-05-26 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists field of the invention
JP2008520579A (en) 2004-11-15 2008-06-19 グラクソ グループ リミテッド Novel M3 muscarinic acetylcholine receptor antagonist
WO2007022351A2 (en) 2005-08-18 2007-02-22 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
AR070562A1 (en) 2008-02-06 2010-04-21 Glaxo Group Ltd DUAL PHARMACOPHORS - PDE4 MUSCARINIC ANTAGONISTS
TW200946526A (en) 2008-02-06 2009-11-16 Glaxo Group Ltd Dual pharmacophores-PDE4-muscarinic antagonistics
AR070563A1 (en) 2008-02-06 2010-04-21 Glaxo Group Ltd COMPOSITE OF A CONDENSED BICYCLE PIRAZOL-PIRIDIN-AMINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF RESPIRATORY DISEASES.
EP4403231A2 (en) 2009-02-26 2024-07-24 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
RU2666963C2 (en) 2012-04-13 2018-09-13 Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Aggregated particles
GB201222679D0 (en) 2012-12-17 2013-01-30 Glaxo Group Ltd Pharmaceutical combination products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800478A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
GB1273823A (en) * 1968-10-22 1972-05-10 Soc Ind Fab Antibiotiques Sifa New tropane derivatives their salts and process for preparation thereof
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US6624167B1 (en) * 2000-08-04 2003-09-23 Targacept, Inc. Pharmaceutical compositions and methods for use

Also Published As

Publication number Publication date
PE20061162A1 (en) 2006-10-14
TW200633706A (en) 2006-10-01
WO2006062883A3 (en) 2007-03-29
AR054411A1 (en) 2007-06-27
WO2006062883A2 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
UY29245A1 (en) MEDICAL COMBINATIONS
UY29244A1 (en) MEDICAL COMBINATIONS
CO6270364A2 (en) PIRIDINE AND PIRAZINE DERIVATIVES USED IN THE TREATMENT OF CELL PROLIFERATION DISORDERS
ECSP088329A (en) NEW DIAZAESPIROALCANOS AND ITS USE FOR THE TREATMENT OF DISEASES MEDIATED BY CCR8
UY28766A1 (en) ADDITIONAL HETEROPOLYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER
CL2007002708A1 (en) COMPOUNDS DERIVED FROM PIRROLO [2,3-B] PIRIDINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER, CAQUEXY, INFLAMMATORY DISORDERS, AMONG OTHERS.
CL2008003096A1 (en) Compounds derived from piperidino-dihydrothienopyrimidines; pde4 inhibitors; pharmaceutical composition comprising them; and use in the treatment of disorders or diseases of the respiratory or gastrointestinal routes, as well as inflammatory diseases of the joints or eyes, among others.
AR057239A1 (en) IMMUNOGLOBULINS
PA8586001A1 (en) INDOL DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES
DOP2006000084A (en) SULFOXIMINO-MACROCICLIC COMPOUNDS AND THEIR SALTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS, PREPARATION METHODS AND USES OF THE SAME
CL2008002139A1 (en) Dimer compounds derived from pyrrolo [2,1c] [1,4] benzodiazepine-5 -one (tomaimycin), a conjugate comprising them; procedure of preparation of conjugates; pharmaceutical composition comprising the compounds or conjugates; and use of compounds and conjugates in the treatment of cancer.
SV2010003451A (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
GT200600163A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
ECSP077349A (en) NEW DERIVATIVES OF SULFONAMIDE AS GLUCOCORTICOID RECEPTOR MODULATORS FOR THE TREATMENT OF INFLAMMATORY DISEASES
ECSP066391A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
WO2006053049A3 (en) Herbal composition phy906 and its use in chemotherapy
ECSP067114A (en) N-SUBSTITUTED PIPERIDINS AND THEIR USE AS PHARMACEUTICALS
UY28922A1 (en) RECEIVER CB1 LINKS USEFUL IN THE TREATMENT OF PAIN AND / OR OTHER SYMPTOMS OR RELATED DISEASES; PHARMACEUTICAL COMPOUNDS AND THEIR PREPARATION.
UY31314A1 (en) HETEROCICLIC AMIDAS AND ITS METHODS OF USE-976
ECSP066978A (en) AMINO COMPOUNDS AND ITS USE AS PHARMACEUTICALS
CL2007001918A1 (en) SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS.
IL184051A (en) Acylated glp-1 compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
UY29087A1 (en) ADAMANTILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE
GT200500325A (en) PIRAZOLO-PIRIMIDINAS 1,4-REPLACED AS QUINASA INHIBITORS
CL2008002852A1 (en) Compounds derived from 7-fluoro-5-methyl-2- (phenylamino) -6,7,8,9-tetrahydro-5h-pyrimido [4,5-b] [1,4] diazepin-6 (7h) -one ; pharmaceutical composition comprising said compounds; and its use in the treatment of cancers, inflammation, alopecia, autoimmune, cardiovascular, infectious, nephrological, neurodfegenerative, skin and bone diseases.